Blood and blisters: porphyria cutanea tarda in myelodysplastic syndrome
Polyclonal hypergammaglobulinaemia with hyperviscosity syndrome
THE LANGERHANS CELL HISTIOCYTOSIS X FILES REVEALED
CHRONIC NEUTROPHILIC LEUKAEMIA: A DISTINCT CLINICAL ENTITY?
SIGNALLING SCAFFOLDS AND ADAPTORS IN T-CELL IMMUNITY
HAEMATOPOIETIC GROWTH FACTORS IN CHILDREN WITH NEUTROPENIA
CELLULAR SIGNALLING PATHWAYS: NEW TARGETS IN LEUKAEMIA THERAPY
Generation of cytokine-induced killer cells from leukaemic samples with in vitro cytotoxicity against autologous and allogeneic leukaemic blasts
The TEL-AML1 real-time quantitative polymerase chain reaction (PCR) might replace the antigen receptor-based genomic PCR in clinical minimal residual disease studies in children with acute lymphoblastic leukaemia
Matrix metalloproteinase-9 and vascular endothelial growth factor: a possible link in adult T-cell leukaemia cell invasion
Efficacy of granulocyte colony-stimulating factor in the treatment of acute myelogenous leukaemia: a multicentre randomized study
Primary effusion lymphomas exhibit complex and recurrent cytogenetic abnormalities
T-cell analysis in identical twins reveals an impaired anti-follicular lymphoma immune response in the patient but not in the healthy twin
Establishment and characterization of a Kaposi's sarcoma-associated herpesvirus- and Epstein-Barr virus-negative malignant lymphoma cell line (OHK) with primary effusion lymphoma immunophenotype
Immunochemical studies of antigenic lymphoma-associated proteins
CD38 expression and secondary 17p deletion are important prognostic factors in chronic lymphocytic leukaemia
Evolution of myelodysplastic syndrome and acute myelogenous leukaemia in children with hepatitis-associated aplastic anaemia
Chronic myeloid leukaemia with marked thrombocytosis in a patient with thalassaemia major: complete haematological remission under the combination of hydroxyurea and anagrelide
High expression of MCL1 gene related to vascular endothelial growth factor is associated with poor outcome in non-Hodgkin's lymphoma
Effects of combinations of therapeutic agents on the proliferation of progenitor cells in chronic myeloid leukaemia
Lamivudine for the treatment of hepatitis B virus reactivation following chemotherapy for non-Hodgkin's lymphoma
t(7;11)(p15;p15) chronic myeloid leukaemia developed into blastic transformation showing a novel NUP98/HOXA11 fusion
Interleukin 8 and venous thrombosis: evidence for a role of inflammation in thrombosis
Mechanisms responsible for the failure of protamine to inactivate low-molecular-weight heparin
Use of the collagen-binding assay for von Willebrand factor in the analysis of type 2M von Willebrand disease: a comparison with the ristocetin cofactor assay
Prior treatment with alpha interferon does not adversely affect the outcome of allogeneic transplantation for chronic myeloid leukaemia
Negative selection of peripheral blood stem cells to support a tandem autologous transplantation programme in multiple myeloma
Predicting long-term (≥ 5 years) event-free survival in multiple myeloma patients following planned tandem autotransplants
In vitro expansion of cord blood does not prevent engraftment of severe combined immunodeficient repopulating cells
A sequence of immuno-chemotherapy with Rituximab, mobilization of in vivo purged stem cells, high-dose chemotherapy and autotransplant is an effective and non-toxic treatment for advanced follicular and mantle cell lymphoma
HOMOZYGOUS FACTOR V LEIDEN MUTATION IN SICKLE CELL ANAEMIA
THE USE OF ORAL VITAMIN K FOR REVERSAL OF OVER-WARFARINIZATION
ALLOGENEIC MARROW GRAFTS FROM UNRELATED DONORS WITH CONGENITAL PERICENTRIC INVERSION OF CHROMOSOME 9
Advanced Haematopathology, 18–22 March 2002
Royal Microscopical Society Course on Flow Cytometry, London, UK, 23-24 April 2002